Account wins

Share this article:
Shire Pharmaceuticals tapped InVentiv's Palio to handle professional advertising and promotion for Fosrenol, which is indicated for hyperphosphatemia in patients with end stage renal disease. Surge Healthcare previously handled the account.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.